1. Home
  2. BPRN vs ANNX Comparison

BPRN vs ANNX Comparison

Compare BPRN & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPRN
  • ANNX
  • Stock Information
  • Founded
  • BPRN 2007
  • ANNX 2011
  • Country
  • BPRN United States
  • ANNX United States
  • Employees
  • BPRN N/A
  • ANNX N/A
  • Industry
  • BPRN Major Banks
  • ANNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BPRN Finance
  • ANNX Health Care
  • Exchange
  • BPRN Nasdaq
  • ANNX Nasdaq
  • Market Cap
  • BPRN 216.1M
  • ANNX 252.3M
  • IPO Year
  • BPRN N/A
  • ANNX 2020
  • Fundamental
  • Price
  • BPRN $29.45
  • ANNX $2.38
  • Analyst Decision
  • BPRN Strong Buy
  • ANNX Strong Buy
  • Analyst Count
  • BPRN 1
  • ANNX 4
  • Target Price
  • BPRN $35.00
  • ANNX $12.50
  • AVG Volume (30 Days)
  • BPRN 10.2K
  • ANNX 1.4M
  • Earning Date
  • BPRN 07-24-2025
  • ANNX 08-11-2025
  • Dividend Yield
  • BPRN 4.08%
  • ANNX N/A
  • EPS Growth
  • BPRN N/A
  • ANNX N/A
  • EPS
  • BPRN 1.67
  • ANNX N/A
  • Revenue
  • BPRN $73,010,000.00
  • ANNX N/A
  • Revenue This Year
  • BPRN $14.19
  • ANNX N/A
  • Revenue Next Year
  • BPRN $15.48
  • ANNX N/A
  • P/E Ratio
  • BPRN $17.66
  • ANNX N/A
  • Revenue Growth
  • BPRN 6.10
  • ANNX N/A
  • 52 Week Low
  • BPRN $27.25
  • ANNX $1.29
  • 52 Week High
  • BPRN $39.35
  • ANNX $7.85
  • Technical
  • Relative Strength Index (RSI)
  • BPRN 42.02
  • ANNX 54.28
  • Support Level
  • BPRN $30.06
  • ANNX $2.26
  • Resistance Level
  • BPRN $29.75
  • ANNX $2.81
  • Average True Range (ATR)
  • BPRN 0.52
  • ANNX 0.21
  • MACD
  • BPRN -0.15
  • ANNX -0.02
  • Stochastic Oscillator
  • BPRN 18.04
  • ANNX 45.68

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: